The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist

Leukemia

Volumn 16, Issue 3, 2002, Pages 316-326

  Abegg, A L ^a   Vickery, L E ^a   Bremer, M E ^a   Donnelly, A M ^a   Doshi, P D ^a   Evans, M L ^a   Thurman, T L ^a   Braford, S R ^a   Caparon, M H ^a   Bauer, S C ^a   Giri, J G ^a   Welply, J K ^a   McKearn, J P ^a   Smith, W G ^a  

^a PFIZER INC   (United States)

Author keywords

Colony forming unit; Granulocyte colony stimulating factor; Hematopoietic growth factors; Interleukin 3; Leridistim

Indexed keywords

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BONE MARROW; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; ERYTHROPOIETIN, RECOMBINANT; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATINICS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-3; MEGAKARYOCYTES; MOLECULAR SEQUENCE DATA; MONOCYTES; RECEPTORS, INTERLEUKIN-3; RECOMBINANT FUSION PROTEINS;

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD34 ANTIGEN; DANIPLESTIM; FIBRINOGEN RECEPTOR; GROWTH FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; LERIDISTIM; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT RECEPTOR; SC 65303; SC 68420; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; BURST FORMING UNIT E; CANCER CHEMOTHERAPY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CHIMERA; COLONY FORMING UNIT; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RESPONSE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MEGAKARYOCYTE; MONOCYTE; PRIORITY JOURNAL; STEM CELL;

EID: 85014133385     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402366     Document Type: Article

References (51)

1. Clinical use of hematopoietic growth factors
2. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes
3. Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF
4. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: Results of a British Multicenter Randomized Trial
5. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
6. Growth factors affecting human thrombocytopoiesis: Potential agents for the treatment of thrombocytopenia
7. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: Results of a prospective randomized trial
8. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF
9. Recombinant gibbon interleukin-3 acts synergistically with recombinant human G-CSF and GM-CSF in vitro
10. Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow
11. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages
12. Growth regulation of hematopoietic cells. An overview
13. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia
14. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers
15. Granulocyte colony-stimulating factor augments in vitro megakaryocyte colony formation by interleukin-3
16. In vitro differentiation of human granulocyte/macrophage and erythroid progenitors: Comparative analysis of the influence of recombinant human erythropoietin, G-CSF, GM-CSF, and IL-3 in serum-supplemented and serum- deprived cultures
17. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures
18. Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1 alpha on the growth of purified human peripheral blood progenitors
19. Interleukin-3 in vivo: Kinetic of response of target cells
20. Interleukin-3: Structure and function
21. Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3
22. The panspecific hemopoietin of activated T lymphocytes (interleukin-3)
23. Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model
24. Saturation mutagenesis of human interleukin-3
25. Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties
26. Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3
27. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells
28. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor
29. Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates
30. Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma
31. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin
32. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors
33. Suppression of apoptosis: Role in cell growth and neoplasia
34. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: Possible sites for intervention with anti-neoplastic drugs
35. Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells
36. + cells that rapidly engraft lethally x-irradiated nonhuman primates
37. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression
38. Circular permutation of granulocyte colony-stimulating factor
39. Molecular analysis of the granulocyte colony-stimulating factor receptor
40. Collagen matrix: An attractive alternative to agar and methylcellulose for the culture of hematopoietic progenitors in autologous transplantation products
41. Terminal differentiation of hemopoietic cell clones cultured in tridimensional collagen matrix: In situ cell morphology and enzyme histochemistry analysis
42. Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels
43. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow
44. + hemopoietic cells
45. Cytokine receptor expression on hematopoietic stem and progenitor cells
46. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma
47. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors
48. Multifactor stimulation of megakaryocytopoiesis: Effects of interleukin 6
49. Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates
50. Leridistem, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: Effect of schedule, dose and route of administration